Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-21
DOI
10.1038/srep29063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A
- (2016) Francesca Mancini et al. PLoS One
- Interleukin-17 and innate immunity in infections and chronic inflammation
- (2015) Natasa Isailovic et al. JOURNAL OF AUTOIMMUNITY
- Safety and immunogenicity of an investigational 4-componentStaphylococcus aureusvaccine with or without AS03Badjuvant: Results of a randomized phase I trial
- (2015) Jack Levy et al. Human Vaccines & Immunotherapeutics
- Rational design of small molecules as vaccine adjuvants
- (2014) T. Y.- H. Wu et al. Science Translational Medicine
- Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza
- (2012) Giuseppe Del Giudice et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
- (2012) Tobias R. Kollmann et al. IMMUNITY
- Epidemiology of invasive meningococcal disease in Germany, 2002–2010, and impact of vaccination with meningococcal C conjugate vaccine
- (2012) Wiebke Hellenbrand et al. JOURNAL OF INFECTION
- Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
- (2011) Nathalie Garçon et al. BIODRUGS
- The design of semi-synthetic and synthetic glycoconjugate vaccines
- (2011) Paolo Costantino et al. Expert Opinion on Drug Discovery
- A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
- (2011) Carlo Iavarone et al. JOURNAL OF IMMUNOLOGY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Alum's adjuvant action: grease is the word
- (2011) M Lamine Mbow et al. NATURE MEDICINE
- Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
- (2011) Timo Vesikari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV‐Infected Adults with a Toll‐Like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial
- (2010) Ole S. Søgaard et al. CLINICAL INFECTIOUS DISEASES
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Glycoconjugate vaccines and immune interference: A review
- (2010) Ron Dagan et al. VACCINE
- How Bacterial Carbohydrates Influence the Adaptive Immune System
- (2009) Fikri Y. Avci et al. Annual Review of Immunology
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
- (2008) Caroline L. Trotter et al. VACCINE
- A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients
- (2007) N.C.T. Kong et al. KIDNEY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now